InflaRx
-$0.08 (-2.54%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell InflaRx and other stocks, options, and ETFs commission-free!
About IFRX
InflaRx N.V. Common Stock, also called InflaRx, is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a.
CEO
Niels Christoph Riedemann
Employees
49
Headquarters
Jena, Thueringen
Founded
2007
IFRX Key Statistics
Market Cap
134.58M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
277.46K
High Today
$3.21
Low Today
$3.05
Open Price
$3.15
Volume
216.54K
52 Week High
$7.46
52 Week Low
$2.66
Analyst Ratings
57%
of 7 ratings
Buy
57.1%
Hold
14.3%
Sell
28.6%
IFRX Earnings
-$0.61
-$0.41
-$0.20
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Jul 29, Pre-Market